$0.95
+0.04 (+4.38%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,315.8% upside
Low Target
$17.80
Average Target
$32.58
High Target
$40.39
Current Price
$0.95
Current
$0.95
$0.95
Target
$32.58
$32.58
$17.80
$32.58 avg
$40.39
Scenario Analysis
Bear Case
$17.80
1,766.2%
Low target
Base Case
$32.58
+3,315.8%
Avg target
Bull Case
$40.39
+4,134.6%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$1.84
-48.1% from high
52-Week Low
$0.77
+24.0% from low
Target vs 52W High
$32.58
+1,671.1% vs high
Next Earnings Report
Nov 14, 2026
Today
EPS Est: $-0.21
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |